サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1750638

細胞培養ビタミンの世界市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測（2025年～2030年）

Cell Culture Vitamins Market Size, Share & Trends Analysis Report By Product, By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 110 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
細胞培養ビタミンの世界市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測（2025年～2030年）
出版日: 2025年05月21日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞培養ビタミン市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の細胞培養ビタミンの市場規模は2030年までに3億4,300万米ドルに達し、2025年～2030年のCAGRは5.6%で成長すると予測されています。この市場は、特にバイオ医薬品の研究開発など、様々な分野で細胞培養技術への依存度が高まっていることから、かなりの成長を遂げています。

細胞培養ビタミン市場の成長を促進する主な要因の1つは、バイオテクノロジーや製薬分野での研究開発（R&D）投資の大幅な増加です。政府、民間団体、学術機関は、革新的な医薬品開発、ワクチン研究、遺伝子治療や細胞治療などの高度な治療技術を支援するための資金配分をますます増やしています。

COVID-19パンデミックは細胞培養ビタミン市場に大きな影響を与えました。ワクチンと生物製剤に対する緊急のニーズは、ビタミンを含む高品質でスケーラブルな細胞培養サプリメントに対する需要を加速させました。このサプリメントは、迅速で安定した生産を確保し、研究を支援し、世界のワクチン需要を満たす効率的な製造工程を可能にする上で極めて重要です。この需要の急増は、ワクチンや治療法の開発における細胞培養培地製剤の重要性を浮き彫りにしました。その結果、パンデミックは細胞培養ビタミンの緊急ニーズを増幅させただけでなく、バイオ医薬品製造における細胞培養ビタミンの重要な役割を浮き彫りにし、市場の成長軌道を強化しました。

がん、糖尿病、自己免疫疾患などの慢性疾患の有病率の上昇により、より高度で的を絞ったヘルスケアソリューションに対する需要が大幅に高まっています。従来の治療法では複雑で長期的な病態に対処できないことが多いため、より個別化された効果的なアプローチを提供する革新的な生物製剤や細胞ベースの治療法へのシフトが進んでいます。これらの先進的な治療法は細胞培養技術に大きく依存しており、成功のためには健康で機能的な細胞を維持することが重要です。これを達成するためには、正確に制御された栄養豊富な培養環境が不可欠であり、特に細胞の成長、分化、免疫反応をサポートするビタミンが豊富に含まれていることが重要です。

細胞培養ビタミン市場レポートのハイライト

  • 製品別では、ビタミンB群セグメントが2024年に39.12%の最大売上シェアを占めました。同市場は、バイオ医薬品製造および研究用途における高品質細胞培養培地への需要増加が牽引しています。
  • 最終用途別では、細胞培養培地メーカーセグメントが市場を独占し、2024年に最大の収益シェアを占めました。生物製剤、ワクチン、細胞療法の大量生産に不可欠な、ビタミン豊富な高級培地に対するバイオ製薬企業や研究センターからのニーズの高まりが、この市場セグメントの拡大に拍車をかけています。
  • 北米は2024年に37.49%の最大シェアを占めました。北米はバイオテクノロジー、医療、医薬品開発をリードしているため、細胞培養ビタミンの需要が高いです。この地域には、ワクチン、抗体治療、細胞療法を開発するトップクラスの研究センターや企業があり、細胞を効率的に増殖させるために、高品質でビタミン豊富な培養培地が必要とされます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 細胞培養ビタミン市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 細胞培養ビタミン市場の分析ツール
    • ポーターの分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 細胞培養ビタミン市場：製品の推定・動向分析

  • 製品セグメントダッシュボード
  • 世界の細胞培養ビタミン市場：製品の変動分析
  • 世界の細胞培養ビタミン市場：規模と動向分析（製品別、2018～2030年）
  • ビタミンB群
    • ビタミンB群の市場規模と予測・動向分析（2018年～2030年）
  • ビタミンA
    • ビタミンAの市場規模と予測・動向分析（2018年～2030年）
  • ビタミンC
    • ビタミンCの市場規模と予測・動向分析（2018年～2030年）
  • その他のビタミン
    • その他のビタミンの市場規模と予測・動向分析（2018年～2030年）

第5章 細胞培養ビタミン市場：最終用途の推定・動向分析

  • 最終用途セグメントダッシュボード
  • 世界の細胞培養ビタミン市場：最終用途の変動分析
  • 世界の細胞培養ビタミン市場：規模と動向分析（最終用途別、2018～2030年）
  • 細胞培養培地メーカー
    • 細胞培養培地メーカーの市場規模と予測・動向分析（2018年～2030年）
  • 製薬・バイオテクノロジー企業
    • 製薬・バイオテクノロジー企業の市場規模と予測・動向分析（2018年～2030年）
  • CDMO/CMOおよびCRO
    • CDMO/CMOおよびCROの市場規模と予測・動向分析（2018年～2030年）

第6章 細胞培養ビタミン市場：地域の推定・動向分析

  • 地域別の市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業/競合の分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル/上場企業
    • DSM-Firmenich
    • Merck KGaA
    • Thermo Fisher Scientific
    • FUJIFILM Irvine Scientific
    • Lonza
    • HiMedia Laboratories
    • Danaher
    • Sartorius AG
    • Corning Inc.
    • R&D Systems（Bio-Techne）
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global cell culture vitamins market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 13 Mexico cell culture vitamins market, by end-use, 2018 - 2030 (USD Million))
  • Table 14 Europe cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 16 Europe cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 18 UK cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Germany cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 France cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 22 France cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Italy cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 24 Italy cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Spain cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 26 Spain cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Denmark cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 28 Denmark cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Sweden cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 30 Sweden cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Norway cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 32 Norway cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Japan cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 China cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 39 China cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 India cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 41 India cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Australia cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 43 Australia cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Thailand cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 47 Thailand cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Latin America cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 50 Latin America cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Brazil cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 52 Brazil cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 MEA cell culture vitamins market, by country, 2018 - 2030 (USD Million)
  • Table 56 MEA cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 57 MEA cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait cell culture vitamins market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait cell culture vitamins market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cell culture vitamins market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Cell culture vitamins market: Product outlook key takeaways
  • Fig. 20 Cell culture vitamins market: Product movement analysis
  • Fig. 21 Vitamin B complex market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Vitamin A market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Vitamin C market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Other vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cell culture vitamins market: End-use outlook key takeaways
  • Fig. 26 Cell culture vitamins market: End-use movement analysis
  • Fig. 27 Cell culture media manufacturers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 CDMOs/ CMOs & CROs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Regional marketplace outlook, 2024 & 2030 (USD million)
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 North America Cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Key country dynamics
  • Fig. 34 U.S. cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 Canada cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Mexico cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Europe cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 UK cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Germany cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 France cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Denmark cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Sweden cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Japan cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 China cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 India cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Australia cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 South Korea cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Thailand cell culture vitamins market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Market participant categorization
  • Fig. 71 Cell culture vitamins market position analysis, 2024
  • Fig. 72 Strategic framework
目次
Product Code: GVR-4-68040-585-3

Cell Culture Vitamins Market Growth & Trends:

The global cell culture vitamins market size is expected to reach USD 343.0 million by 2030 and is expected to grow at 5.6% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has experienced considerable growth as there is an increase in reliance on cell culture technologies across various sectors, particularly in biopharmaceutical research and development

One of the key drivers propelling the growth of the cell culture vitamins market is the significant rise in research and development (R&D) investments across the biotechnology and pharmaceutical sectors. Governments, private organizations, and academic institutions increasingly allocate funds to support innovative drug development, vaccine research, and advanced therapeutic techniques such as gene and cell therapies.

The COVID-19 pandemic has had a profound impact on the cell culture vitamins market. The urgent need for vaccines and biologics accelerated demand for high-quality, scalable cell culture supplements, including vitamins, which are critical in ensuring rapid and consistent production, supporting research, and enabling efficient manufacturing processes to meet global vaccine demand. This surge in demand underscored the importance of cell culture media formulations in vaccine and therapeutic development. Consequently, the pandemic not only amplified the immediate need for cell culture vitamins but also highlighted their essential role in biopharmaceutical manufacturing, thereby reinforcing the market's growth trajectory

The rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune disorders, has significantly increased the demand for more advanced and targeted healthcare solutions. As traditional treatments often fall short in addressing complex and long-term conditions, there is a growing shift toward innovative biologics and cell-based therapies that offer more personalized and effective approaches. These advanced therapies rely heavily on cell culture technologies, where maintaining healthy and functional cells is critical for success. To achieve this, precisely controlled, nutrient-rich culture environments become essential, particularly those enriched with vitamins that support cell growth, differentiation, and immune response.

Cell Culture Vitamins Market Report Highlights:

  • Based on product, the vitamin B complex segment accounted for the largest revenue share of 39.12% in 2024. The market is driven by increasing demand for high-quality cell culture media in biopharmaceutical manufacturing and research applications.
  • Based on end use, the cell culture media manufacturers segment dominated the market and accounted for the largest revenue share in 2024. Growing needs from biopharmaceutical firms and research centers for premium, vitamin-rich culture media, essential for mass production of biologics, vaccines, and cell therapies, are fueling this market segment's expansion.
  • North America held the largest share of 37.49% in 2024. North America has a high demand for cell culture vitamins because it leads in biotechnology, medicine, and drug development. The region is home to top research centers and companies that create vaccines, antibody treatments, and cell therapies, all of which need high-quality, vitamin-rich culture media to grow cells effectively.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Cell Culture Vitamins Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising demand for biopharmaceuticals
      • 3.2.1.2. Growing investment in R&D
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Stringent regulatory requirements
  • 3.3. Cell Culture Vitamins Market Analysis Tools
    • 3.3.1. Porter's Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cell Culture Vitamins Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Cell Culture Vitamins Market Product Movement Analysis
  • 4.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Cell Culture Vitamins
    • 4.4.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 4.5. Cell Culture Vitamins
    • 4.5.1. Cell Culture Vitamins Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 5. Cell Culture Vitamins Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Global Cell Culture Vitamins Market End Use Movement Analysis
  • 5.3. Global Cell Culture Vitamins Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Cell Culture Media Manufacturers
    • 5.4.1. Cell Culture Media Manufacturers Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.5. Pharmaceutical & Biotechnology Companies
    • 5.5.1. Pharmaceutical & Biotechnology Companies Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
  • 5.6. CDMOs/ CMOs & CROs
    • 5.6.1. CDMOs/ CMOs & CROs Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)

Chapter 6. Cell Culture Vitamins Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. DSM-Firmenich
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Merck KGaA
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Thermo Fisher Scientific
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. FUJIFILM Irvine Scientific
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Lonza
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. HiMedia Laboratories
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Danaher
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Sartorius AG
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Corning Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. R&D Systems (Bio-Techne)
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives